ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 59 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $262,500 | -93.2% | 105,000 | -88.3% | 0.00% | -94.1% |
| Q3 2021 | $3,840,000 | +26.7% | 895,200 | -10.5% | 0.02% | +21.4% |
| Q2 2021 | $3,030,000 | -12.3% | 1,000,000 | -3.6% | 0.01% | -12.5% |
| Q1 2021 | $3,456,000 | -34.5% | 1,037,700 | -45.3% | 0.02% | -42.9% |
| Q4 2019 | $5,274,000 | +278.6% | 1,897,284 | +744.5% | 0.03% | +366.7% |
| Q3 2017 | $1,393,000 | – | 224,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 16,013,540 | $39,233,000 | 1.19% |
| ARMISTICE CAPITAL, LLC | 1,940,000 | $4,753,000 | 1.12% |
| DAFNA Capital Management LLC | 234,000 | $573,000 | 0.50% |
| Alpha Wave Global, LP | 1,655,162 | $4,055,000 | 0.43% |
| Telemetry Investments, L.L.C. | 150,000 | $368,000 | 0.21% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,294,945 | $12,972,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 792,617 | $1,942,000 | 0.11% |
| K2 PRINCIPAL FUND, L.P. | 443,887 | $1,088,000 | 0.10% |
| Anson Funds Management LP | 105,085 | $257,000 | 0.08% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 25,000 | $61,000 | 0.03% |